Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication

dc.contributor.authorWilson, Lauren
dc.contributor.authorGage, Peter
dc.contributor.authorEwart, Gary
dc.date.accessioned2015-12-07T22:33:05Z
dc.date.issued2006
dc.date.updated2015-12-07T10:27:14Z
dc.description.abstractAll coronaviruses encode a small hydrophobic envelope (E) protein, which mediates viral assembly and morphogenesis by an unknown mechanism. We have previously shown that the E protein from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) forms cation-selective ion channels in planar lipid bilayers (Wilson, L., McKinlay, C., Gage, P., Ewart, G., 2004. SARS coronavirus E protein forms cation-selective ion channels. Virology 330(1), 322-331). We now report that three other E proteins also form cation-selective ion channels. These E proteins were from coronaviruses representative of taxonomic groups 1-3: human coronavirus 229E (HCoV-229E), mouse hepatitis virus (MHV), and infectious bronchitis virus (IBV), respectively. It appears, therefore, that coronavirus E proteins in general, belong to the virus ion channels family. Hexamethylene amiloride (HMA) - an inhibitor of the HIV-1 Vpu virus ion channel - inhibited the HCoV-229E and MHV E protein ion channel conductance in bilayers and also inhibited replication of the parent coronaviruses in cultured cells, as determined by plaque assay. Conversely, HMA had no antiviral effect on a recombinant MHV with the entire coding region of E protein deleted (MHVΔE). Taken together, the data provide evidence of a link between inhibition of E protein ion channel activity and the antiviral activity of HMA.
dc.identifier.issn0042-6822
dc.identifier.urihttp://hdl.handle.net/1885/23103
dc.publisherAcademic Press
dc.sourceVirology
dc.subjectKeywords: amiloride derivative; hexamethylene amiloride; ion channel; unclassified drug; virus protein; virus protein e; animal cell; antiviral activity; article; Avian infectious bronchitis virus; cell culture; controlled study; Coronavirus; Murine hepatitis coron Amiloride; Antiviral compound; Coronavirus; E protein; Hexamethylene amiloride (HMA); Human coronavirus 229E (HCoV-229E); Infectious bronchitis virus (IBV); Ion channel; Mouse hepatitis virus (MHV)
dc.titleHexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication
dc.typeJournal article
local.bibliographicCitation.lastpage306
local.bibliographicCitation.startpage294
local.contributor.affiliationWilson, Lauren, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationGage, Peter, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationEwart, Gary, Biotron Ltd
local.contributor.authoremailrepository.admin@anu.edu.au
local.contributor.authoruidWilson, Lauren, u9715160
local.contributor.authoruidGage, Peter, u8404889
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor119999 - Medical and Health Sciences not elsewhere classified
local.identifier.ariespublicationu4020362xPUB25
local.identifier.citationvolume353
local.identifier.doi10.1016/j.virol.2006.05.028
local.identifier.scopusID2-s2.0-33748714028
local.identifier.uidSubmittedByu4020362
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
01_Wilson_Hexamethylene_amiloride_blocks_2006.pdf
Size:
1.15 MB
Format:
Adobe Portable Document Format